Rovi stock trades at EUR 58.10, 9.4 percent above its 52-week low
Published on 10/09/2026 at 18:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Rovi stock traded at EUR 58.10 at Lang & Schwarz on October 9, 2026 at 6:33 p.m. CEST, down 0.68 percent from EUR 58.50.
- The EUR 53.10 to EUR 86.70 52-week range places the price 9.4 percent above its low.
- Rovi reported first-half 2026 revenue growth of 13.2 percent, while the next results are scheduled for November 5, 2026.
Rovi (ISIN ES0157261019) traded at EUR 58.10 at Lang & Schwarz on October 9, 2026 at 6:33 p.m. CEST, down 0.68 percent from the EUR 58.50 prior close. The price was 9.4 percent above its 52-week low of EUR 53.10 and 32.99 percent below its 52-week high of EUR 86.70.
Price sits near yearly low
The 52-week range of EUR 53.10 to EUR 86.70 gives the current price a clear placement within the annual band. Rovi was also trading below its EUR 86.70 high by EUR 28.60, while the gap to the low stood at EUR 5.00, both as of October 9, 2026.
The Lang & Schwarz quote listed a bid of EUR 57.95 and an ask of EUR 58.25 at 6:33 p.m. CEST. Trading volume for the Madrid-listed shares was 56,180, versus an average volume of 108,606 shares as of October 9, 2026.
Valuation and next results
Rovi had a market capitalization of EUR 3.0 billion and a P/E ratio of 16.04 as of October 9, 2026. Investing.com listed a 12-month average analyst target of EUR 74.36 and nine analysts on October 9, 2026.
In the first half of 2026, Rovi reported total revenue growth of 13.2 percent and gross margin expansion of 6.5 percentage points, according to the company investor page dated July 23, 2026. The next scheduled event is the first nine months 2026 financial results on November 5, 2026, according to Rovi.
Comparison with peers
Rovi (BME, EUR): minus 0.68 percent, P/E 16.0, market capitalization EUR 3.0 billion
Almirall (BME, EUR): plus 0.20 percent, P/E 30.4, market capitalization EUR 2.2 billion
Grifols (BME, EUR): plus 2.02 percent, P/E 14.8, market capitalization EUR 6.7 billion
After-hours price check
Rovi's after-hours quote was EUR 58.10 at Lang & Schwarz on October 9, 2026 at 6:33 p.m. CEST. The minus 0.68 percent move versus the EUR 58.50 prior close keeps the stock close to the lower end of its annual range rather than near its EUR 86.70 high.
The further course of trading is shown by the continuously updated real-time quote of Rovi stock.
Rovi stock facts
- Company: Laboratorios Farmaceuticos Rovi, S.A.
- ISIN: ES0157261019
- Ticker: ROVI
- Primary exchange: BME Madrid
- Price Lang & Schwarz as of October 9, 2026 at 6:33 p.m. CEST: EUR 58.10
- Change versus prior close: minus 0.68 percent
- Prior close Lang & Schwarz October 8, 2026: EUR 58.50
- Market capitalization: EUR 3.0 billion as of October 9, 2026
- 52-week range: EUR 53.10-EUR 86.70 as of October 9, 2026
- Sector / Industry: Healthcare / Drug Manufacturers - Specialty and Generic
- Next earnings date: November 5, 2026
Market context: Market report IBEX 35.
